DOCSLIB.ORG

Discovery Centre Opens in Dundee FEBS-EMBO Anniversary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Discovery Centre Opens in Dundee FEBS-EMBO Anniversary AUTUMN 2014 ISSUE 28 Discovery Centre FEBS-EMBO opens Anniversary in Dundee Conference PAGE 13 PAGES 2 – 3 irgile Delâtre FEBS-EMBO JOINT ANNIVERSARY CONFERENCE ©V The mental maps of bees PAGES 6 –7 Feature Members of the Polish EMBO Interview EMBO Member David Ron from Feature Behind the scenes of the European community present their research at the Cambridge Institute of Medical Research Union-funded BioMedBridges project which the BIO 2014 Congress in Warsaw. describes the benefts of agitation. is building infrastructure and a culture for shared data in the life sciences . PAGE 5 PAGE 11 PAGE 4 www.embo.org THE FEBS–EMBO ANNIVERSARY 2014 CONFERENCE ©Virgile Delâtre reveal about the incredible geographic migra- Highlights from the FEBS-EMBO tion of humans over the years. “Modern humans originated in Africa and began their migration to other parts of the world almost 100 000 to 125 000 Anniversary Conference in Paris years ago,” said Pääbo. His work, which involves painstaking analysis of often scarce amounts of he FEBS-EMBO Anniversary Conference of “Mr. FEBS” Satya Prakash Datta. Whelan first genetic material recovered from human bones in hosted by the French Society for proposed a journal for the rapid communication remote locations, has helped to build up a picture TBiochemistry and Molecular Biology of short reports in biochemistry, biophysics and of the influence of Neanderthals on the migration (SFBBM) took place in Paris from 30 August to 4 molecular biology in 1967. Datta played a key of humans out of Africa, through parts of Europe September. More than 2500 scientists from over role in establishing and running FEBS Letters and into Asia. Pääbo’s work on ancient DNA has 60 countries came together to listen to six excit- which went on to be very successful. At the meet- successfully distinguished at the genetic level ing days of talks from leading researchers in the ing, the EMBO and FEBS journals collaborated to what makes us different from our Neanderthal life sciences and to celebrate the joint anniversa- award prizes for the best posters of the day and cousins. His recent book “Neanderthal man: ries of EMBO, FEBS and the SFBBM. the winning posters were displayed in a special In search of lost genomes,” which comprises “I would like to extend a warm thank you to area of the conference. memoirs from his career, was recently published everyone who contributed to an outstanding In the opening scientific lectures, Catherine by Basic Books. anniversary meeting in Paris,” said Maria Leptin, Dulac from Harvard University and Svante Pääbo On the second day of the meeting, Thomas Director of EMBO. “It was a wonderful event that from the Max Planck institute for Evolutionary Stocker from the University of Bern gave a reflected both the excitement and excellence of Anthropology in Leipzig described their latest special plenary lecture on climate change. science in Europe. I am convinced that the rela- scientific work. Dulac’s talk focused on how “Climate change is the biggest challenge of the tionships we have established between our organ- the mouse brain is geared for social interaction. century,” commented EMBO Secretary General izations will serve us well in the years ahead.” She outlined the striking antagonistic interac- Sir Paul Nurse in his introduction to the talk. Marie-Christine Lemardeley from the Office tions in brain systems that underlie parental of the Mayor of Paris opened the meeting and care and infant-directed aggression in both male VIDEO remarked that she was particularly looking and female mice. Remarkably the mouse brain forward to the opening lecture by Svante Pääbo has the infrastructure to support male or female and the session on transparent publishing. After child-rearing characteristics. “Highly conserved welcoming remarks from EMBO, FEBS and circuits and modulatory mechanisms may exist SFBBM, Gottfried Schatz and William Whelan across species and in both male and female brains revealed the early histories and development to regulate parental interactions with offspring,” of EMBO and FEBS, respectively. “EMBO is said Dulac. The fine line that divides the differ- unashamedly elitist,” said Schatz. “It has never ences in mental processes in mice for what we joined the mania of big science. I hope its heart would call good and bad parenting is striking. Catherine Dulac Brain function and chromatin plasticity will beat vigorously for years to come.” William Dulac believes that studying these processes in Harvard University Professor Catherine Whelan, the first Secretary General of FEBS, has mice will help reveal the complexities of human Dulac talks about the role of histone, the been an active participant in the activities of parental behavior and its susceptibility to mental basis of memory, and the future of molecular FEBS since it took its first steps 50 years ago. illness. neurosciences. He emphasized the importance of the contribu- Svante Pääbo’s talk focused on the origins tions of the FEBS journals to the development of and evolution of humans. He described what new http://serious-science.org/videos/934 the society as well as the crucial contributions DNA sequencing technologies have been able to 2 EMBOencounters | Autumn 2014 | [email protected] ©2014 EMBO THE FEBS–EMBO ANNIVERSARY 2014 CONFERENCE “The consequences for the planet are huge if oceans to see what a dramatic effect humans cancer and cardiovascular disease. Rapamycin we do not limit it.” Stocker described how the have had on the planet. There has been a huge received clinical approval in 1999 for use in the Intergovernmental Panel on Climate Change had change in energy content down to a depth of 2 prevention of organ rejection in kidney transplant put together their most recent assessment enti- km, almost 250 x 1021 Joules over the years 1970 patients. Torisel and Afinitor were approved in tled Climate Change 2013: The Physical Science to 2010. This is greater than the energy output 2007 and 2009, respectively, for the treatment of Basis. A four-year project with input from 259 of the world for a year.” Limiting climate change advanced kidney cancer. Hall went on to present scientists and approval from governments around will require substantial and sustained reductions a unified model for TOR signaling in genetics and the world, the report documents the evidence in greenhouse gas emissions. “There is no magic biochemistry. for human influence on the world’s climate. bullet to reduce emissions from fossil fuels,” said Other highlights at the meeting included a Warming of the climate system is unequivo- Stocker “but we have a choice.” plenary session on epigenetics. The session cal, say the contributors to the report, and it Michael Hall delivered the FEBS Sir Hans Krebs ended with talks from EMBO Members David is extremely likely that human influence is the Lecture describing the discovery of TOR (target Baulcombe, Wolf Reik and Susan Gasser. The dominant cause of the observed warming since of rapamycin) and its role in signaling events for FEBS-EMBO Anniversary Conference included 30 the mid-20th century. “One only has to look at growth and metabolism. Since its discovery in concurrent sessions that spanned the cell cycle, the change in the energy content of the world’s 1991, around 3000 papers have been published chromosome structure, cilia and disease, mito- in the scientific literature on TOR (2012 data). He chondria and mitochondrial disease, stem cells, went on to describe some of the applications that microbiology and synthetic biology. Four plenary have arisen from this work. Research on TOR sessions explored topics that included bioin- has resulted in drugs to prevent organ rejection formatics, genomics, epigenetics, the immune during transplantations and new ways to treat system, cell biology and systems biology. Participants at the FEBS-EMBO anniversary conference in the Exhibition Hall in Paris ©Virgile Delâtre design for the medal that we award to young The EMBO scientists for outstanding contributions to the life sciences in Europe.” The new design created by the EMBO graph- Gold Medal ic design team not only includes a fresh repre- SOPHIE MARTIN of the University sentation of the cell but also incorporates new elements that reflect, for example, the more of Lausanne, Switzerland, received quantitative aspects of molecular biology. the 2014 EMBO Gold Medal at Martin has been working for the past 15 the FEBS-EMBO Anniversary years to understand cellular polarity, in particu- lar the way in which the spatial organization of Conference in Paris. The medal cells contributes to cell size and cell division. ©Virgile Delâtre was awarded for her work to In the last 11 years, she has been using fission understand the molecular events yeast, which grow as single, rod-shaped cells, as a model system for her investigations. that define the organization and Martin and her team have revealed how development of the cell. gradients of specific control proteins at the extremities of the cell contribute to the control he Gold Medal has been redesigned for of cell growth and the ultimate size of the cell. TEMBO’s anniversary year. “2014 is the “I have always been fascinated by how perfect year to introduce a new look for the biological processes are spatially organized EMBO Gold Medal,” commented EMBO within cells. I feel incredibly lucky not only to Director Maria Leptin. “We wanted to mark the have the freedom to study this basic problem occasion of our 50th anniversary with a new but to be rewarded for it,” said Martin. ©2014 EMBO EMBOencounters | Autumn 2014 | [email protected] 3 NEWS FROM THE EMBO COMMUNITY when studying diseases that affect different organ- Building bridges for isms in the same way: the effectiveness of possi- ble treatments for human patients can be tested translational research on mouse models.
Load more

Recommended publications
  • Spring 2021 Bulletin
    Advancing Access to Civil Justice STEPS TOWARD INTERNATIONAL CLIMATE GOVERNANCE Featuring William Nordhaus, Pinelopi Goldberg, and Scott Barrett HONORING WILLIAM LABOV, RUTH LEHMANN , AND GERTRUD SCHÜPBACH SPRING 2021 SELECT UPCOMING VIRTUAL EVENTS May 6 A Conversation with Architect 27 Reflections on a Full, Consequential, Jeanne Gang and Lucky Life: Science, Leadership, Featuring: Jeanne Gang and Education Featuring: Walter E. Massey (left) in conversation with Don Randel (right) June 14 Lessons Learned from Reckoning with Organizational History Featuring: John J. DeGioia, Brent Leggs, Susan Goldberg, Claudia Rankine, and Ben Vinson 13 Finding a Shared Narrative Hosted by the Library of Congress Featuring: Danielle Allen, winner of the Library’s 2020 Kluge Prize Above: “Our Common Purpose” featuring the Juneteenth flag with one star. Artist: Rodrigo Corral For a full and up-to-date listing of upcoming events, please visit amacad.org/events. SPRING 2021 CONTENTS Flooding beside the Russian River on Westside Road in Healdsburg, Sonoma County, California; February 27, 2019. Features 16 Steps Toward International 38 Honoring Ruth Lehmann and Gertrud Climate Governance Schüpbach with the Francis Amory Prize William Nordhaus, Pinelopi Goldberg, and Scott Barrett Ruth Lehmann and Gertrud Schüpbach 30 Honoring William Labov with the Talcott Parsons Prize William Labov CONTENTS 5 Among the contributors to the Dædalus issue on “Immigration, Nativism & Race” (left to right): Douglas S. Massey (guest editor), Christopher Sebastian Parker, and Cecilia Menjívar Our Work 5 Dædalus Explores Immigration, Nativism & Race in the United States 7 Advancing Civil Justice Access in the 21st Century 7 10 New Reports on the Earnings & Job Outcomes of College Graduates 14 Our Common Purpose in Communities Across the Country Members 53 In Memoriam: Louis W.
    [Show full text]
  • Laureadas Com O Nobel Na Fisiologia Ou Medicina (1995-2015)
    No trono da ciência II: laureadas com o Nobel na Fisiologia ou Medicina (1995-2015) On the Throne of Science II: Nobel Laureates in Physiology or Medicine (1995-2015) LUZINETE SIMÕES MINELLA Universidade Federal de Santa Catarina | UFSC RESUMO O artigo dá continuidade a uma pesquisa mais ampla sobre as trajetórias das doze cientistas que receberam o Nobel na Fisiologia ou Medicina entre 1947 e 2015. Na fase anterior foram analisadas as trajetó- rias das cinco pioneiras, laureadas entre 1947 e 1988 e nesta segunda etapa, são abordadas suas sucessoras, as sete premiadas entre 1995 e 2015. A análise das suas autobiografias, discursos e palestras disponíveis no site do prêmio, além de outras fontes, se fundamenta numa perspectiva balizada pela crítica feminista à ciência bem como pelos avanços dos estudos do campo de gênero e ciências e da história da ciência. O artigo tenta identificar semelhanças e diferenças entre as pioneiras e as sucessoras na tentativa de contribuir para o debate sobre as especificidades da feminização das carreiras científicas. 85 Palavras-chave Gênero e Ciências – Nobel – Fisiologia ou Medicina. ABSTRACT The article gives continuity to a broader research on the trajectories of the twelve scientists who received the Nobel Prize in Physiology or Medicine between 1947 and 2015. In the previous phase, the trajectories of the five pioneers awarded between 1947 and 1988 were analyzed, and, in this second phase, their successors, the seven awarded between 1995 and 2015, were approached. The analysis of their autobiographies, speeches and lectures available on the award site, in addition to other sources, is based on a feminist critique of science as well as advances of the studies in the field of gender and science and the history of science.
    [Show full text]
  • Medical Advisory Board September 1, 2006–August 31, 2007
    hoWard hughes medical iNstitute 2007 annual report What’s Next h o W ard hughes medical i 4000 oNes Bridge road chevy chase, marylaNd 20815-6789 www.hhmi.org N stitute 2007 a nn ual report What’s Next Letter from the president 2 The primary purpose and objective of the conversation: wiLLiam r. Lummis 6 Howard Hughes Medical Institute shall be the promotion of human knowledge within the CREDITS thiNkiNg field of the basic sciences (principally the field of like medical research and education) and the a scieNtist 8 effective application thereof for the benefit of mankind. Page 1 Page 25 Page 43 Page 50 seeiNg Illustration by Riccardo Vecchio Südhof: Paul Fetters; Fuchs: Janelia Farm lab: © Photography Neurotoxin (Brunger & Chapman): Page 3 Matthew Septimus; SCNT images: by Brad Feinknopf; First level of Rongsheng Jin and Axel Brunger; iN Bruce Weller Blake Porch and Chris Vargas/HHMI lab building: © Photography by Shadlen: Paul Fetters; Mouse Page 6 Page 26 Brad Feinknopf (Tsai): Li-Huei Tsai; Zoghbi: Agapito NeW Illustration by Riccardo Vecchio Arabidopsis: Laboratory of Joanne Page 44 Sanchez/Baylor College 14 Page 8 Chory; Chory: Courtesy of Salk Janelia Farm guest housing: © Jeff Page 51 Ways Illustration by Riccardo Vecchio Institute Goldberg/Esto; Dudman: Matthew Szostak: Mark Wilson; Evans: Fred Page 10 Page 27 Septimus; Lee: Oliver Wien; Greaves/PR Newswire, © HHMI; Mello: Erika Larsen; Hannon: Zack Rosenthal: Paul Fetters; Students: Leonardo: Paul Fetters; Riddiford: Steitz: Harold Shapiro; Lefkowitz: capacity Seckler/AP, © HHMI; Lowe: Zack Paul Fetters; Map: Reprinted by Paul Fetters; Truman: Paul Fetters Stewart Waller/PR Newswire, Seckler/AP, © HHMI permission from Macmillan Page 46 © HHMI for Page 12 Publishers, Ltd.: Nature vol.
    [Show full text]
  • Profile of Gary Ruvkun
    PROFILE Profile of Gary Ruvkun wash in the faint glow of a fluo- Brush with Molecular Biology rescent lamp, a pair of serpentine The story of Ruvkun’s metamorphosis Anematode worms lie on a Petri from a keen undergraduate into a leading plate, their see-through bodies light in his field of study begins at Har- magnified 100-fold by one of several vard University, where he enrolled in microscopes arrayed in a darkened bay in a Ph.D. program in 1976 upon returning National Academy of Sciences member to the United States. Like many other Gary Ruvkun’s laboratory at Massachu- scientific institutions across the world in setts General Hospital. While one of the the mid-1970s, Harvard was astir with the worms wiggles its way around the plate, promise of recombinant DNA technol- the other shows no signs of life, ogy, and Ruvkun wasted no time em- its midsection ruptured and its innards bracing its tools. “My undergraduate strewn asunder. A filter slides into place, education had not prepared me at all for and the worms are bathed in a dull recombinant DNA, but I immersed my- green haze. The wiggling worm has a bea- self into its culture at Harvard, much of con of nerve cells in its head, the ganglia which was James Watson’s creation from lit up by a genetic trick that has rescued a decade earlier,” Ruvkun says. Propelled the worm from death; its neighbor wears Gary Ruvkun. by a desire to be a part of the culture of no such beacon. The worms were deprived basic molecular biology, all while per- of a tiny RNA molecule, called a micro- forming science with the potential to im- RNA, which helps shepherd them through not 5-year-old children.
    [Show full text]
  • 2008 Harvard / Paul F
    The 2008 Harvard / Paul F. Glenn Symposium on Aging June 23, 2008 Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Welcome to the 3rd Annual Harvard/Paul F. Glenn Symposium on Aging. Each year, the Paul F. Glenn Laboratories host the Harvard Symposium on Aging with a mission to educate the wider research community about advancements in this fast-paced field and to stimulate collaborative research in this area. We have been fortunate to have many of the leaders in the aging field speak at these symposia. As a result, attendees come not only from the Harvard research community but from across the nation and from overseas for this one day event. We are glad you could join us here today. The reasons for accelerating research molecular biology of aging are clear. First and foremost, the number of aged individuals in developed countries is growing rapidly, which is going to place an unprecedented burden on the families and the economies of those nations. Because chronic illness in the elderly is a major medical cost, enormous savings would be achieved if mortality and morbidity could be compressed within a shorter duration of time at the end of life. A study by the RAND Corporation in 2006 concluded that advances in medicine arising from aging research would be 10-100 times more cost-effective than any other medical breakthrough. Advances in aging research have shown that it is possible to extend the healthy lifespan of laboratory animals through genetic and pharmacological means. Many leaders in the aging field predict that significant strides will be made in understanding how human health and lifespan are regulated, leading to novel medicines to forestall and treat diseases of aging such as diabetes, cancer, Alzheimer’s and heart disease.
    [Show full text]
  • Science & Policy Meeting Jennifer Lippincott-Schwartz Science in The
    SUMMER 2014 ISSUE 27 encounters page 9 Science in the desert EMBO | EMBL Anniversary Science & Policy Meeting pageS 2 – 3 ANNIVERSARY TH page 8 Interview Jennifer E M B O 50 Lippincott-Schwartz H ©NI Membership expansion EMBO News New funding for senior postdoctoral In perspective Georgina Ferry’s enlarges its membership into evolution, researchers. EMBO Advanced Fellowships book tells the story of the growth and ecology and neurosciences on the offer an additional two years of financial expansion of EMBO since 1964. occasion of its 50th anniversary. support to former and current EMBO Fellows. PAGES 4 – 6 PAGE 11 PAGES 16 www.embo.org HIGHLIGHTS FROM THE EMBO|EMBL ANNIVERSARY SCIENCE AND POLICY MEETING transmissible cancer: the Tasmanian devil facial Science meets policy and politics tumour disease and the canine transmissible venereal tumour. After a ceremony to unveil the 2014 marks the 50th anniversary of EMBO, the 45th anniversary of the ScienceTree (see box), an oak tree planted in soil European Molecular Biology Conference (EMBC), the organization of obtained from countries throughout the European member states who fund EMBO, and the 40th anniversary of the European Union to symbolize the importance of European integration, representatives from the govern- Molecular Biology Laboratory (EMBL). EMBO, EMBC, and EMBL recently ments of France, Luxembourg, Malta, Spain combined their efforts to put together a joint event at the EMBL Advanced and Switzerland took part in a panel discussion Training Centre in Heidelberg, Germany, on 2 and 3 July 2014. The moderated by Marja Makarow, Vice President for Research of the Academy of Finland.
    [Show full text]
  • Is Neuroscience a Bigger Threat Than Artifical Intelligence
    Is Neuroscience a Bigger Threat than Artificial Intelligence? IBM’s Jeopardy winning computer Watson is a serious threat, not just to the livelihood of medical diagnosticians, but to other professionals who may find themselves going the way of welders. Besides its economic threat, the advance of AI seems to pose a cultural threat: if physical systems can do what we do without thought to give meaning to their achievements, the conscious human mind will be displaced from its unique role in the universe as a creative, responsible, rational agent. But this worry has a more powerful basis in the Nobel Prize winning discoveries of a quartet of neuroscientists—Eric Kandel, John O’Keefe, Edvard, and May-Britt Moser. For between them they have shown that the human brain doesn’t work the way conscious experience suggests at all. Instead it operates to deliver human achievements in the way IBM’s Watson does. Thoughts with meaning have no more role in the human brain than in artificial intelligence. Consciousness tells us that we employ a theory of mind, both to decide on our own actions and to predict and explain the behavior of others. According to this theory there have to be particular belief/desire pairings somewhere in our brains working together to bring about movements of the body, including speech and writing. Which beliefs and desires in particular? Roughly speaking it’s the contents of beliefs and desires—what they are about—that pair them up to drive our actions. The desires represent the ends, the beliefs record the available means to attain them.
    [Show full text]
  • The Roles of Atf3 in Stress-Regulated Signal Transduction
    THE ROLES OF ATF3 IN STRESS-REGULATED SIGNAL TRANSDUCTION AND CELL DEATH IN PANCREATIC BETA-CELLS DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Matthew G. Hartman, B.S. * * * * * The Ohio State University 2005 Dissertation Committee: Approved by Dr. Tsonwin Hai, Advisor Dr. Gary Kociba Advisor Dr. James DeWille Molecular, Cellular and Developmental Biology Program Dr. John Oberdick ABSTRACT Currently there are 20 million people diagnosed with diabetes in the United States and the incidence is expected to increase by 42% over the next twenty years. Type 1, or insulin-dependent diabetes, is an autoimmune disorder characterized by infiltration of activated T-lymphocytes into the pancreas. Auto- reactive immune cells initiate β-cell destruction by several mechanisms including secretion of soluble factors (cytokines), direct cell-cell contact, and activation of osmotic lysis signals. Type 2, or insulin-independent diabetes, is characterized by insulin resistance in the peripheral tissues such as the liver, fat, and skeletal muscle. Phosphorylation of key substrates involved in the insulin signal transduction pathway by stress-activated protein kinases contributes to the insulin resistance and prevents the uptake of glucose from the blood. Recent reports suggest that type 2 diabetes is a slower progressing form of type 1 and that β-cell apoptosis contributes to the pathogenesis of both forms. Activating Transcription Factor 3 (ATF3) is a member of the ATF/CREB family of transcription factors which regulate gene expression through their ability to bind a common DNA sequence motif (TGACGTCA).
    [Show full text]
  • The 2014 Nobel Prize in Physiology Or Medicine John O´Keefe May-Britt
    PRESS RELEASE 2014‐10‐06 The Nobel Assembly at Karolinska Institutet has today decided to award The 2014 Nobel Prize in Physiology or Medicine with one half to John O´Keefe and the other half jointly to May‐Britt Moser and Edvard I. Moser for their discoveries of cells that constitute a positioning system in the brain ____________________________________________________________________________________________________ How do we know where we are? How can we find the way from one place to another? And how can we store this information in such a way that we can immediately find the way the next time we trace the same path? This year´s Nobel Laureates have discovered a positioning system, an “inner GPS” in the brain that makes it possible to orient ourselves in space, demonstrating a cellular basis for higher cognitive function. In 1971, John O´Keefe discovered the first component of this positioning system. He found that a type of nerve cell in an area of the brain called the hippocampus that was always activated when a rat was at a certain place in a room. Other nerve cells were activated when the rat was at other places. O´Keefe concluded that these “place cells” formed a map of the room. More than three decades later, in 2005, May‐Britt and Edvard Moser discovered another key component of the brain’s positioning system. They identified another type of nerve cell, which they called “grid cells”, that generate a coordinate system and allow for precise positioning and pathfinding. Their subsequent research showed how place and grid cells make it possible to determine position and to navigate.
    [Show full text]
  • ERC Press Release O in 2012, Prof
    Press release 6 October 2014 Nobel Prize in Physiology/Medicine to two European Research Council grantees It was announced today by the Nobel Assembly at Karolinska Institutet, Stockholm, that the 2014 Nobel Prize in Physiology/Medicine has been awarded to Professor Edvard I. Moser and Professor May-Britt Moser, both ERC Advanced Grant holders, together with Professor John O´Keefe, "for their discoveries of cells that constitute a positioning system in the brain". On this occasion, European Commission President José Manuel Barroso said: "I warmly congratulate John O´Keefe, May-Britt Moser and Edvard Moser on their achievement. I am particularly proud that both May-Britt and Edvard Moser are holders of European Research Council Advanced Grants. The ERC supports the very best pioneering researchers across Europe, and has made a real impact since its launch in 2007. This is why we decided on a significant boost for the ERC budget in our new research and innovation programme, Horizon 2020." The President of the European Research Council (ERC), Prof. Jean-Pierre-Bourguignon, commented: "On behalf of the ERC, I would like to extend warm congratulations to this year’s three Nobel laureates in Physiology or Medicine. We are very proud that the European Research Council has funded two of the winners - Professors Edvard I. Moser and May-Britt Moser. Their ERC Advanced Grants contributed in a significant way to their ground-breaking research on the navigation system of the brain. Today's news confirms that the ERC invests in the best minds – whether young or senior - to support their most innovative ideas at the cutting edge." This is the third time that a Nobel Prize goes to top researchers funded by the ERC since its launch.
    [Show full text]
  • About Whitehead Institute for Biomedical Research Selected
    About Whitehead Institute for Biomedical Research Selected Achievements in FOUNDING VISION Biomedical Science Whitehead Institute is a nonprofit, independent biomedical research institute with pioneering programs in cancer research, developmental biology, genetics, and Isolated the first tumor suppressor genomics. It was founded in 1982 through the generosity of Edwin C. "Jack" Whitehead, gene, the retinoblastoma gene, and a businessman and philanthropist who sought to create a new type of research created the first genetically defined institution, one that would exist outside the boundaries of a traditional academic human cancer cells. (Weinberg) institution, and yet, through a teaching affiliation with the Massachusetts Institute of Technology (MIT), offer all the intellectual, collegial, and scientific benefits of a leading Isolated key genes involved in diabetes, research university. hypertension, leukemia, and obesity. (Lodish) WHITEHEAD INSTITUTE TODAY True to its founding vision, the Institute gives outstanding investigators broad freedom Mapped and cloned the male- to pursue new ideas, encourages novel collaborations among investigators, and determining Y chromosome, revealing a accelerates the path of scientific discovery. Research at Whitehead Institute is unique self-repair mechanism. (Page) conducted by 22 principal investigators (Members and Fellows) and approximately 300 visiting scientists, postdoctoral fellows, graduate students, and undergraduate Developed a method for genetically students from around the world. Whitehead Institute is affiliated with MIT in its engineering salt- and drought-tolerant teaching activities but wholly responsible for its own research programs, governance, plants. (Fink) and finance. Developed the first comprehensive cellular LEADERSHIP network describing how the yeast Whitehead Institute is guided by a distinguished Board of Directors, chaired by Sarah genome produces life.
    [Show full text]
  • Dr. Paul Janssen Award for Biomedical Research Issues 2015
    Press Contacts: Dr. Paul Janssen Award for Biomedical Research Issues Seema Kumar 2015 Call for Nominations 908-405-1144 (M) [email protected] New Brunswick, N.J. – January 21, 2015 – The Dr. Paul Janssen Award for Diane Pressman Biomedical Research today opens its 2015 call for nominations. This prestigious 908-927-6171 (O) award recognizes individuals whose scientific research has made, or has the [email protected] potential to make, significant contributions toward the improvement of human Frederik Wittock health. Nominations will be accepted until March 15, 2015 at +32 14 60 57 24 (O) www.pauljanssenaward.com for consideration by an independent selection [email protected] committee of world renowned scientists. Beginning in 2015, the cash prize awarded to the scientist or group of scientists receiving the Award will be increased to $200,000. This increase in the monetary award reflects the growing importance of basic biomedical research, and continued recognition by Johnson & Johnson of excellence in the field. The Dr. Paul Janssen Award for Biomedical Research honors Dr. Paul Janssen (1926-2003), who is widely recognized as one of the most productive scientists of the 20th century. Known throughout the scientific community as “Dr. Paul,” Janssen was responsible for breakthrough treatments in disease areas including pain management, psychiatry, infectious disease and gastroenterology, and founded Janssen Pharmaceutica, N.V., a Johnson & Johnson Company. “Innovative science and technology have the power to transform the world,” said Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson. “Through the Dr. Paul Janssen Award for Biomedical Research, Johnson & Johnson honors the inspirational legacy of Dr.
    [Show full text]